Horizon Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11M | Sell |
22,215
-2,220
| -9% | -$984K | 0.12% | 137 |
|
|
2026
Q1 | $10.9M | Buy |
24,435
+13,060
| +115% | +$6.09M | 0.12% | 139 |
|
|
2025
Q4 | $5.16M | Buy |
11,375
+2,181
| +24% | +$940K | 0.07% | 243 |
|
|
2025
Q3 | $3.6M | Buy |
9,194
+1,352
| +17% | +$565K | 0.05% | 298 |
|
|
2025
Q2 | $3.49M | Buy |
7,842
+2,793
| +55% | +$1.29M | 0.06% | 258 |
|
|
2025
Q1 | $2.45M | Buy |
5,049
+80
| +2% | +$37.3K | 0.07% | 172 |
|
|
2024
Q4 | $2M | Buy |
4,969
+86
| +2% | +$39.9K | 0.06% | 186 |
|
|
2024
Q3 | $2.27M | Sell |
4,883
-55
| -1% | -$26.4K | 0.06% | 159 |
|
|
2024
Q2 | $2.31M | Sell |
4,938
-134
| -3% | -$58.2K | 0.06% | 143 |
|
|
2024
Q1 | $2.12M | Buy |
5,072
+182
| +4% | +$76.9K | 0.06% | 155 |
|
|
2023
Q4 | $1.99M | Buy |
4,890
+403
| +9% | +$149K | 0.06% | 149 |
|
|
2023
Q3 | $1.56M | Buy |
4,487
+56
| +1% | +$19.6K | 0.05% | 137 |
|
|
2023
Q2 | $1.56M | Sell |
4,431
-196
| -4% | -$66K | 0.04% | 138 |
|
|
2023
Q1 | $1.46M | Sell |
4,627
-2,636
| -36% | -$791K | 0.04% | 137 |
|
|
2022
Q4 | $2.1M | Sell |
7,263
-3,638
| -33% | -$1.11M | 0.06% | 132 |
|
|
2022
Q3 | $3.16M | Buy |
10,901
+7,448
| +216% | +$2.14M | 0.1% | 83 |
|
|
2022
Q2 | $973K | Sell |
3,453
-7,917
| -70% | -$2.12M | 0.03% | 187 |
|
|
2022
Q1 | $2.97M | Buy |
11,370
+1,904
| +20% | +$452K | 0.08% | 113 |
|
|
2021
Q4 | $2.08M | Buy |
9,466
+6,725
| +245% | +$1.31M | 0.06% | 141 |
|
|
2021
Q3 | $497K | Sell |
2,741
-839
| -23% | -$164K | 0.01% | 324 |
|
|
2021
Q2 | $722K | Buy |
3,580
+1,128
| +46% | +$236K | 0.02% | 258 |
|
|
2021
Q1 | $527K | Buy |
+2,452
| New | +$539K | 0.02% | 285 |
|
|
2020
Q4 | – | Sell |
-7,238
| Closed | -$1.97M | – | 394 |
|
|
2020
Q3 | $1.97M | Buy |
7,238
+2,380
| +49% | +$657K | 0.07% | 127 |
|
|
2020
Q2 | $1.41M | Buy |
4,858
+1,640
| +51% | +$445K | 0.03% | 191 |
|
|
2020
Q1 | $766K | Buy |
3,218
+393
| +14% | +$90.2K | 0.04% | 147 |
|
|
2019
Q4 | $619K | Buy |
2,825
+1,233
| +77% | +$250K | 0.03% | 247 |
|
|
2019
Q3 | $270K | Sell |
1,592
-87
| -5% | -$15.4K | 0.01% | 280 |
|
|
2019
Q2 | $308K | Buy |
1,679
+348
| +26% | +$60.8K | 0.01% | 373 |
|
|
2019
Q1 | $245K | Buy |
+1,331
| New | +$246K | 0.01% | 320 |
|
Other funds holding VRTX
Horizon Investments's VRTX Position: Q2 2026 in Review
Horizon Investments reduced its Vertex Pharmaceuticals (VRTX) stake by 9.1% in Q2 2026, selling an estimated $984K and leaving 22,215 shares worth $11M. The position accounts for 0.12% of the portfolio, ranked #137.
Horizon Investments first reported a position in VRTX in Q1 2019 and has held it in 29 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Horizon Investments held 22,215 shares of Vertex Pharmaceuticals worth $11M as of Q2 2026.
- Horizon Investments sold 2,220 Vertex Pharmaceuticals shares in Q2 2026, an estimated $984K.
- Vertex Pharmaceuticals made up 0.12% of Horizon Investments's portfolio in Q2 2026, its #137 holding.
- Horizon Investments first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 29 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.